IS8491A - Nýtt efnasamband, samsvarandi blöndur, framleiðslu- og/eða meðhöndlunaraðferðir - Google Patents

Nýtt efnasamband, samsvarandi blöndur, framleiðslu- og/eða meðhöndlunaraðferðir

Info

Publication number: IS8491A
Authority: IS; Iceland
Prior art keywords: production; treatment methods; new compound; corresponding mixtures; mixtures
Prior art date: 2003-11-12

Application number

IS8491A

Other languages

English (en)

Inventor

C. Dell'orco Philip

Marie Diederich Ann

Su Qiaogang

Lee Wood Jeffrey

Original Assignee

Smithkline Beecham Corporation

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2003-11-12

Filing date

2006-05-30

Publication date

2006-05-30

2006-05-30 Application filed by Smithkline Beecham Corporation filed Critical Smithkline Beecham Corporation

2006-05-30 Publication of IS8491A publication Critical patent/IS8491A/is

Links

150000001875 compounds Chemical class 0.000 title 1
238000000034 method Methods 0.000 title 1
239000000203 mixture Substances 0.000 title 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/22—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains four or more hetero rings
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/4738—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
General Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Virology (AREA)
Communicable Diseases (AREA)
Oncology (AREA)
Epidemiology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicinal Preparation (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)

IS8491A 2003-11-12 2006-05-30 Nýtt efnasamband, samsvarandi blöndur, framleiðslu- og/eða meðhöndlunaraðferðir IS8491A (is)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
US51916003P	2003-11-12	2003-11-12
US52457403P	2003-11-24	2003-11-24
PCT/US2004/037626 WO2005046608A2 (en)	2003-11-12	2004-11-12	Novel compound, corresponding compositions, preparation and/or treatment methods

Publications (1)

Publication Number	Publication Date
IS8491A true IS8491A (is)	2006-05-30

Family

ID=34594951

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
IS8491A IS8491A (is)	2003-11-12	2006-05-30	Nýtt efnasamband, samsvarandi blöndur, framleiðslu- og/eða meðhöndlunaraðferðir

Country Status (16)

Country	Link
US (2)	US7754733B2 (is)
EP (1)	EP1689400A4 (is)
JP (1)	JP2007510751A (is)
KR (1)	KR20060122847A (is)
CN (1)	CN1913897B (is)
AR (1)	AR046579A1 (is)
AU (1)	AU2004289318B2 (is)
BR (1)	BRPI0416366A (is)
CA (1)	CA2545876A1 (is)
IL (1)	IL175369A (is)
IS (1)	IS8491A (is)
MA (1)	MA28179A1 (is)
NO (1)	NO20062616L (is)
RU (1)	RU2352572C2 (is)
TW (1)	TWI333492B (is)
WO (1)	WO2005046608A2 (is)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
AR046579A1 (es) *	2003-11-12	2005-12-14	Smithkline Beecham Corp	Compuesto cristalino de topotecan, composicion farmaceutica que lo comprende, procedimiento para prepararlo y su uso para preparar dicha composicion farmaceutica
WO2007042799A1 (en) *	2005-10-10	2007-04-19	Cipla Limited	Novel crystalline forms
US7547785B2 (en) *	2005-12-26	2009-06-16	Dr. Reddy's Laboratories Limited	Process for preparing topotecan
US7977483B2 (en) *	2007-04-11	2011-07-12	Scinopharm Taiwan, Ltd.	Process for making topotecan
NZ580516A (en)	2007-04-19	2012-02-24	Scinopharm Taiwan Ltd	Crystalline forms of topotecan hydrochloride and processes for making the same
US7572803B2 (en) *	2007-10-25	2009-08-11	The Christus Stehlin Foundation For Cancer Research	Hydrated crystalline esters of camptothecin
ITMI20072268A1 (it)	2007-12-04	2009-06-05	Antibioticos Spa	Polimorfi cristallini di topotecan cloridrato con elevato grado di purezza e metodi per la loro preparazione
KR20250008774A (ko)	2022-05-11	2025-01-15	셀진 코포레이션	T 세포 요법 및 그의 생산과 관련된 방법 및 용도

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5004758A (en) *	1987-12-01	1991-04-02	Smithkline Beecham Corporation	Water soluble camptothecin analogs useful for inhibiting the growth of animal tumor cells
DK0547165T3 (da) *	1990-09-28	2000-03-27	Smithkline Beecham Corp	Fremgangsmåde til fremstilling af vandopløselige camptothecinanaloger såvel som forbindelserne 10-hydroxy-11-C(1-6)-alkoxyc
FR2757514B1 (fr) *	1996-12-20	1999-02-12	Sod Conseils Rech Applic	Nouveaux analogues de la camptothecine, des procedes de preparation, leur application comme medicaments et les compositions pharmaceutiques les contenant
FR2790261B1 (fr) *	1999-02-26	2004-09-10	Sod Conseils Rech Applic	Nouveaux analogues optiquement purs de la camptothecine et leurs procedes de preparation
IT1282673B1 (it) *	1996-02-23	1998-03-31	Ist Naz Stud Cura Dei Tumori	Derivati della camptotecina e loro uso come agenti antitumorali
ATE223417T1 (de) *	1996-12-19	2002-09-15	Reddy Research Foundation	Wasserlösliche c-ring analoge des 20(s)- camphothecins
AR013261A1 (es) *	1997-08-01	2000-12-13	Smithkline Beecham Corp	Formulaciones farmaceuticas para analogos de camptotecina en capsula de gelatina
CA2461089A1 (en) *	2001-09-25	2003-04-03	Dr. Reddy's Laboratories Ltd.	Pharmaceutically acceptable salts of 20(s)-camptothecins
US6482830B1 (en) *	2002-02-21	2002-11-19	Supergen, Inc.	Compositions and formulations of 9-nitrocamptothecin polymorphs and methods of use therefor
AR046579A1 (es) *	2003-11-12	2005-12-14	Smithkline Beecham Corp	Compuesto cristalino de topotecan, composicion farmaceutica que lo comprende, procedimiento para prepararlo y su uso para preparar dicha composicion farmaceutica
WO2007042799A1 (en)	2005-10-10	2007-04-19	Cipla Limited	Novel crystalline forms
US7547785B2 (en)	2005-12-26	2009-06-16	Dr. Reddy's Laboratories Limited	Process for preparing topotecan
NZ580516A (en)	2007-04-19	2012-02-24	Scinopharm Taiwan Ltd	Crystalline forms of topotecan hydrochloride and processes for making the same
ITMI20072268A1 (it)	2007-12-04	2009-06-05	Antibioticos Spa	Polimorfi cristallini di topotecan cloridrato con elevato grado di purezza e metodi per la loro preparazione

2004
- 2004-11-10 AR ARP040104146A patent/AR046579A1/es not_active Application Discontinuation
- 2004-11-10 TW TW093134191A patent/TWI333492B/zh not_active IP Right Cessation
- 2004-11-12 KR KR1020067009179A patent/KR20060122847A/ko not_active Ceased
- 2004-11-12 US US10/578,660 patent/US7754733B2/en not_active Expired - Lifetime
- 2004-11-12 CA CA002545876A patent/CA2545876A1/en not_active Abandoned
- 2004-11-12 JP JP2006539849A patent/JP2007510751A/ja active Pending
- 2004-11-12 CN CN2004800403007A patent/CN1913897B/zh not_active Expired - Fee Related
- 2004-11-12 RU RU2006120422/04A patent/RU2352572C2/ru not_active IP Right Cessation
- 2004-11-12 AU AU2004289318A patent/AU2004289318B2/en not_active Ceased
- 2004-11-12 WO PCT/US2004/037626 patent/WO2005046608A2/en not_active Ceased
- 2004-11-12 EP EP04810731A patent/EP1689400A4/en not_active Withdrawn
- 2004-11-12 BR BRPI0416366-4A patent/BRPI0416366A/pt not_active IP Right Cessation
2006
- 2006-05-01 IL IL175369A patent/IL175369A/en not_active IP Right Cessation
- 2006-05-24 MA MA29057A patent/MA28179A1/fr unknown
- 2006-05-30 IS IS8491A patent/IS8491A/is unknown
- 2006-06-07 NO NO20062616A patent/NO20062616L/no not_active Application Discontinuation
2010
- 2010-04-30 US US12/770,898 patent/US8158645B2/en not_active Expired - Lifetime

Also Published As

Publication number	Publication date
WO2005046608A3 (en)	2005-11-03
CN1913897B (zh)	2010-08-11
BRPI0416366A (pt)	2007-03-13
WO2005046608B1 (en)	2005-12-29
AR046579A1 (es)	2005-12-14
NO20062616L (no)	2006-07-12
US8158645B2 (en)	2012-04-17
RU2006120422A (ru)	2007-12-27
TWI333492B (en)	2010-11-21
MA28179A1 (fr)	2006-09-01
TW200530250A (en)	2005-09-16
EP1689400A2 (en)	2006-08-16
WO2005046608A2 (en)	2005-05-26
US20070117832A1 (en)	2007-05-24
AU2004289318B2 (en)	2010-04-29
CA2545876A1 (en)	2005-05-26
IL175369A0 (en)	2008-04-13
JP2007510751A (ja)	2007-04-26
RU2352572C2 (ru)	2009-04-20
EP1689400A4 (en)	2006-12-27
CN1913897A (zh)	2007-02-14
KR20060122847A (ko)	2006-11-30
IL175369A (en)	2012-03-29
US7754733B2 (en)	2010-07-13
AU2004289318A1 (en)	2005-05-26
US20100210677A1 (en)	2010-08-19

Publication	Publication Date	Title
DE50203563D1 (de)	2005-08-11	Rollosystem
DE60324888D1 (de)	2009-01-08	und Herstellungsverfahren
DK1673750T3 (da)	2014-01-20	Sikkerhedsovervågningssystem
NO20055459D0 (no)	2005-11-18	Prosesser
DE502004002801D1 (de)	2007-03-15	Bohrlochbehandlungsmittel, enthaltend ethercarbonsäuren
NO20044662L (no)	2005-01-14	Forbindelser, blandinger og fremgangsmater
DE602004010856D1 (de)	2008-02-07	Bohrlochbehandlungsflüssigkeiten
DE60305332D1 (de)	2006-06-22	IMIDAZOi1,2-AöPYRIDINE
NO20054967D0 (no)	2005-10-26	Ammoniakk oksidasjonsprosess
DE50310909D1 (de)	2009-01-22	Zweiradschloss
DE602004024025D1 (de)	2009-12-24	Gebissbefestigung, gebiss und herstellungsverfahren dafür
IS8491A (is)	2006-05-30	Nýtt efnasamband, samsvarandi blöndur, framleiðslu- og/eða meðhöndlunaraðferðir
DE60322942D1 (de)	2008-09-25	Textilbehandlung
NO20035401D0 (no)	2003-12-04	Metode
FR2844822B1 (fr)	2005-06-24	Serrure
NO20034281D0 (no)	2003-09-25	Lås
DE602004030793D1 (de)	2011-02-10	Asynchrones flimmerreduktionsverfahren
NO20053189D0 (no)	2005-06-29	HVC-kombinasjonsterapi.
FR2852345B1 (fr)	2012-02-10	Serrure
ATA80192002A (de)	2003-02-15	Türschloss
NL1026889A1 (nl)	2005-03-01	Beugelslot.
NO20031166D0 (no)	2003-03-13	Behandlingsmetode
NO20034256D0 (no)	2003-09-24	Behandlingsmetode
SE0301477D0 (sv)	2003-05-20	New process
SE0302380D0 (sv)	2003-09-04	New process